Literature DB >> 6257300

Action of ortho- and paramyxovirus neuraminidase on gangliosides. Hydrolysis of ganglioside GM1 by Sendai virus neuraminidase.

Y Suzuki, T Morioka, M Matsumoto.   

Abstract

The action of neuraminidase of influenza A virus, Sendai virus and Newcastle disease virus particles on bovine brain ganglioside GM1 and the properties of Sendai virus neuraminidase for GM1 were studied. With Sendai virus, GM1 was hydrolyzed to asialo-GM1 (GA1) and N-acetylneuraminic acid even in the absence of surfactant or other additives, while the hydrolysis of GM1 by Newcastle disease virus or influenza A virus was very low or undetectable under the same conditions. The formation of GA1 by Sendai virus neuraminidase was confirmed by thin-layer chromatography and immunodiffusion test using anti-GA1 antiserum. The apparent Km of Sendai virus neuraminidase for GM1 hydrolysis was found to be 2.67 x 10(-4) M and the optimum pH was 5.6. GM3, GM2 and oligosaccharide of GM1 were hydrolyzed more effectively than GM1 in the absence of surfactant (GM3 greater than GM2 greater than oligosaccharide of GM1 greater than GM1). The hydrolysis of GM1 by the Sendai virus enzyme was stimulated by the addition of sodium cholate or sodium taurocholate, but was inhibited by divalent cations (10 mM), Ca2+, Mg2+, ZN2+, Fe2+ and CU2+. In the absence of the surfactant, Sendai virus neuraminidase hydrolyzed GM1 more efficiently than Arthobacter ureafaciens neuraminidase which has been reported recently as being an adequate enzyme to hydrolyze ganglioside GM1 as a substrate.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6257300

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Sialidase of swine influenza A viruses: variation of the recognition specificities for sialyl linkages and for the molecular species of sialic acid with the year of isolation.

Authors:  G Xu; T Suzuki; Y Maejima; T Mizoguchi; M Tsuchiya; M Kiso; A Hasegawa; Y Suzuki
Journal:  Glycoconj J       Date:  1995-04       Impact factor: 2.916

2.  Synthetic sialylphosphatidylethanolamine derivatives bind to human influenza A viruses and inhibit viral infection.

Authors:  C T Guo; C H Wong; T Kajimoto; T Miura; Y Ida; L R Juneja; M J Kim; H Masuda; T Suzuki; Y Suzuki
Journal:  Glycoconj J       Date:  1998-11       Impact factor: 2.916

3.  Live Imaging of Virus-Infected Cells by Using a Sialidase Fluorogenic Probe.

Authors:  Tadanobu Takahashi; Yuuki Kurebayashi; Tadamune Otsubo; Kiyoshi Ikeda; Akira Minami; Takashi Suzuki
Journal:  Methods Mol Biol       Date:  2021

4.  Single-amino-acid substitution in an antigenic site of influenza virus hemagglutinin can alter the specificity of binding to cell membrane-associated gangliosides.

Authors:  Y Suzuki; H Kato; C W Naeve; R G Webster
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

5.  An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein.

Authors:  M A Markwell; A Portner; A L Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

6.  New ganglioside analogs that inhibit influenza virus sialidase.

Authors:  Y Suzuki; K Sato; M Kiso; A Hasegawa
Journal:  Glycoconj J       Date:  1990       Impact factor: 2.916

7.  Enzymatic Substrates and Fluorescence Imaging of Influenza Virus Sialidase.

Authors:  Yuuki Kurebayashi; Tadanobu Takahashi; Takashi Suzuki
Journal:  Methods Mol Biol       Date:  2022

8.  Characterization of gangliosides of porcine erythrocyte membranes: occurrence of ganglioside GD3 as major ganglioside.

Authors:  Y Suzuki; N Suzuki; H Michi; M Matsumoto
Journal:  Lipids       Date:  1985-09       Impact factor: 1.880

9.  Edible bird's nest extract inhibits influenza virus infection.

Authors:  Chao-Tan Guo; Tadanobu Takahashi; Wakoto Bukawa; Noriko Takahashi; Hirokazu Yagi; Koichi Kato; Kazuya I-P Jwa Hidari; Daisei Miyamoto; Takashi Suzuki; Yasuo Suzuki
Journal:  Antiviral Res       Date:  2006-03-03       Impact factor: 5.970

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.